Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2006; 12(4): 595-602
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.595
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.595
Table 1 Sources of antibodies and ratio of dilutions used in this study
| Antibody | Source | Dilution |
| CD117 monoclonal | Dako M7140 Clone104D2 | 1:50 |
| CD 34 monoclonal | Dako M7161 CloneQBEnd10 | 1:200 |
| Desmin monoclonal | Novocastra NCL-DES-DERII | 1:100 |
| Clone DE-R-11 | ||
| Smooth muscle | ||
| actin monoclonal | Novocastra NCL-SMA Clone αsm | 1:50 |
| S-100 polyclonal | Novocastra NCL-S100p | 1:1 500 |
| P53 monoclonal | Dako | 1:200 |
| Ki67 monoclonal | Dako MIB1 | 1:50 |
| PCNA monoclonal | Dako M0879 | 1:50 |
- Citation: Hu TH, Chuah SK, Lin JW, Chiu YC, Changchien CS, Wang CC, Chen YS, Yi LN, Chiu KW, Lee CM. Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese. World J Gastroenterol 2006; 12(4): 595-602
- URL: https://www.wjgnet.com/1007-9327/full/v12/i4/595.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i4.595